{"skill":{"slug":"bms-bristol-myers","displayName":"Bms Bristol Myers","summary":"Provides insights on BMS's strategic shift from traditional pharma to immuno-oncology leader with key drugs Opdivo and Yervoy and major acquisitions like Cel...","tags":{"latest":"1.0.0"},"stats":{"comments":0,"downloads":49,"installsAllTime":0,"installsCurrent":0,"stars":0,"versions":1},"createdAt":1777323746692,"updatedAt":1777324609717},"latestVersion":{"version":"1.0.0","createdAt":1777323746692,"changelog":"- 初始发布：提供百时美施贵宝（BMS）的历史、战略转型与业务概览\n- 覆盖大型并购（收购Celgene）和免疫肿瘤学战略\n- 展示核心产品（Opdivo、Revlimid、Eliquis）及其市场影响\n- 包含公司商业模式、护城河分析和关键数据\n- 增加行业有趣事实和里程碑时间线","license":"MIT-0"},"metadata":null,"owner":{"handle":"hanxueyuan","userId":"s17eht14r6y7ztwaw37n96ka7583eghn","displayName":"hanxueyuan","image":"https://avatars.githubusercontent.com/u/16717383?v=4"},"moderation":null}